Orlando Harmon
Multiple sclerosis (MS) is a chronic disease that requires lifelong treatment, and the costs of medication can be high. The average yearly cost of MS treatment is estimated to be around $88,487, including direct treatment costs like prescription medications and doctor's appointments, as well as non-medical costs. The price of MS medication has increased significantly, with some medications increasing by around 1,000% in the last 20 years. This has made it difficult for many patients to afford their treatment, even with insurance. However, there are programs and foundations that can help with the costs, and some medications are covered by insurance plans.
| Characteristics | Values |
|---|---|
| Affordability | MS medication is expensive and costs are rising |
| Treatment costs | Average yearly cost of treatment is $88,487 |
| Direct treatment costs | Prescription medications and doctor's appointments |
| Non-medical costs | Everyday living with MS, e.g. early retirement, home modifications, transport to healthcare providers |
| Insurance coverage | Out-of-pocket expenses vary depending on insurance coverage |
| Medicare | Medicare supplement (Medigap) plan can cover some out-of-pocket costs |
| Patient assistance programs | Offered by pharmaceutical companies, non-profit assistance foundations, and diagnosis-based assistance programs |
| OCREVUS® (ocrelizumab) | Annual list price of $78,858, but most people pay less depending on insurance coverage |
| Kesimpta (ofatumumab) | Covered by most Medicare and insurance plans |
| Betaseron (interferon beta-1b) | Covered by some Medicare and insurance plans |
Explore related products
What You'll Learn
MS medication costs with private insurance
The cost of MS medication with private insurance will depend on several factors, including the type of insurance and plan, the prescribed medication and dosage, and whether you can access discounts or financial support. While insurance can cover most MS treatments, out-of-pocket expenses can be significant and are rising.
Medicare, for example, covers the cost of MS treatments, but only if they are considered medically necessary. Original Medicare does not cover medications unless administered in a facility or a doctor's office. However, you can purchase a Part D plan to supplement your Original Medicare coverage, which covers prescription medications, including those for MS. Part C or Medicare Advantage plans also provide coverage for MS medications and services.
The cost of medications on a Part D formulary, or list of covered medications, depends on the pricing tier they fall under. Additionally, Medicare Supplement Insurance (Medigap) plans can help cover some out-of-pocket costs associated with Medicare, but they do not cover services that Medicare does not already cover.
Out-of-pocket costs for MS patients can be substantial, and these costs depend largely on the treatments received and the insurance coverage. Some insurance plans may have a deductible that must be met before coverage begins. After meeting the deductible, patients may still owe coinsurance, or a percentage of the total cost, up to a maximum out-of-pocket amount.
To manage these costs, patients can explore patient assistance programs offered by pharmaceutical companies and nonprofit organizations. These programs can help cover or reduce out-of-pocket expenses, but they may have income limits or other eligibility requirements. Examples of such programs include Good Days, The Assistance Fund, The Healthwell Foundation, and The Patient Access Network (PAN) Foundation. Additionally, websites like NeedyMeds.org provide information on diagnosis-based assistance programs for MS, including those that help with insurance copayments.
Medical Recliner Coverage: What Does Insurance Actually Cover?
You may want to see also
Explore related products
Medicare supplement plans
The cost of treating multiple sclerosis (MS) can be high, with many patients facing significant medical expenses. Medicare can cover some of these costs, depending on the type of plan you have and the specific services you require.
Medicare Part A covers inpatient hospital stays, limited skilled care in your home, and short stays at skilled nursing facilities. It also covers any treatments and medications received while admitted to a facility. Medicare Part B, which together with Part A makes up Original Medicare, covers a wide range of medical services, including durable medical equipment (DME) deemed medically necessary, such as devices to manage MS. Part B also covers mental health counselling, which is often required to treat depression and other mental health issues associated with MS.
Medicare Part C, also known as Medicare Advantage, covers at least as much as Original Medicare, and so includes all the services covered by Parts A and B. Medicare Part C also covers physical and occupational therapy if it is deemed medically necessary. Medicare Part D provides coverage for prescription drugs, including medications to manage MS. Original Medicare does not cover these medications unless received in a facility or at a doctor's office.
Medicare Supplement Insurance (Medigap) plans can be purchased to cover some of the out-of-pocket costs associated with Original Medicare. These plans can help with upfront costs but do not cover services not included in Medicare. If you have Original Medicare, Medigap can be a useful secondary insurance to help manage the costs of MS treatment.
The cost of MS medication with insurance depends on the specific plan and its formulary, or list of covered medications. Each insurance plan differs in its out-of-pocket costs, so contacting your insurance provider is the best way to understand what you will be expected to pay. Additionally, there are patient assistance programs offered by pharmaceutical companies and non-profit organisations that can help with the costs of MS medication. These include programs offered by the National Multiple Sclerosis Society, the Multiple Sclerosis Association of America, and the Genentech Patient Foundation.
Understanding Minnesota Medical Insurance: Duration and Coverage Limits
You may want to see also
Explore related products
Nonprofit assistance foundations
The cost of MS medication depends on several factors, including the type of medication and your insurance coverage. For example, the list price of OCREVUS (ocrelizumab), a prescription medicine used to treat relapsing or primary progressive forms of multiple sclerosis, is $78,858 annually, but most people won't pay the full amount. If you have commercial or private insurance, you may be eligible for OCREVUS Co-Pay assistance.
If you're struggling to afford MS medication, even with insurance, nonprofit assistance foundations may be able to help. Here are some organizations that can provide support and resources:
The National Multiple Sclerosis Society
The National Multiple Sclerosis Society is a great resource for finding patient assistance programs and other financial resources for MS medication. They list several pharmaceutical companies that offer patient assistance programs for MS medications, as well as additional resources such as The Assistance Fund and GoodDays. They also provide information on other nonprofit groups, including the HealthWell Foundation, Patient Access Network (PAN) Foundation, and the Patient Advocate Foundation.
Multiple Sclerosis Association of America (MSAA)
The MSAA is another excellent resource for MS patients. They provide a list of patient assistance programs offered by pharmaceutical companies and also list nonprofit groups that can help with costs. Additionally, the MSAA offers important MS-related news, updates on their programs, and easy ways to support the MS community.
The Multiple Sclerosis Foundation (MS Focus)
MS Focus helps people living with MS maintain the best possible quality of life. They provide assistance with affording care services, medical devices, and lifestyle aids, such as wheelchair ramps. Their website offers educational resources, advocacy initiatives, volunteering opportunities, and support groups.
The Myelin Repair Foundation
This foundation focuses on raising funds for myelin repair research treatments. Since 2004, they have contributed to numerous studies and helped identify new treatment targets and tools. Their website provides information on their current clinical trials, research achievements, and testimonials from doctors and researchers.
The Consortium of Multiple Sclerosis Centers (CMSC)
The CMSC is an organization for MS healthcare and research professionals. They focus on education, research, advocacy, and collaboration within the MS field. The affiliated CMSC foundation supports research initiatives and offers scholarships and awards for those working in this area.
Race to Erase MS
This nonprofit organization funds a network of top MS research centers in the United States, helping them collaborate and avoid redundancies in research. Since its founding in 1993, Race to Erase MS has raised over $36 million for MS research.
Rocky Mountain MS Center
In partnership with the University of Colorado, the Rocky Mountain MS Center has a team of scientists and physicians working on innovative MS therapies. They have one of the largest MS research programs in the world and offer educational resources and therapeutic treatment options.
In addition to these nonprofit foundations, you may also consider obtaining secondary insurance to supplement Medicare. A Medicare supplement (Medigap) plan can help cover additional out-of-pocket costs. Remember to regularly check the websites of these organizations and foundations, as eligibility requirements and application periods may vary.
Medical Insurance Companies: Billion-Dollar Revenue and Counting
You may want to see also
Explore related products
Pharmaceutical company programs
The cost of MS medication with insurance can vary depending on the treatment and the insurance coverage. Out-of-pocket costs can be high, and patients may be left paying thousands of dollars even with insurance. The National Multiple Sclerosis Society lists patient assistance programs offered by pharmaceutical companies that can help with the cost of MS medications. These programs can provide support based on eligibility, and it is worth contacting them to understand what help is available. The Multiple Sclerosis Association of America also provides information on nonprofit assistance foundations that can help with costs, including The Assistance Fund and GoodDays. Additionally, NeedyMeds.org lists over 30 diagnosis-based assistance programs for multiple sclerosis, which can help with insurance copayments and provide assistive equipment.
- Patient Assistance Programs: Many pharmaceutical companies offer patient assistance programs that provide financial assistance or medication access to eligible individuals. These programs often have specific criteria for qualification, such as income thresholds or lack of insurance coverage. By enrolling in these programs, patients may receive medications at reduced costs or even for free.
- Medication Discounts and Rebates: Pharmaceutical companies may offer discounts, rebates, or coupons for their MS medications. These can help lower the out-of-pocket expenses for patients. For example, GoodRx is a website that helps patients find prescription drug costs and coupons, potentially reducing their financial burden.
- Medication Access Programs: Some pharmaceutical companies may have medication access programs that provide free or low-cost medications to patients who cannot afford them. These programs often have eligibility criteria based on financial need or lack of insurance coverage. Enrolling in such programs can ensure that patients have access to their necessary medications.
- Support Services: In addition to financial assistance, pharmaceutical companies may offer support services to help patients manage their MS. These services could include therapy-specific centres of excellence, specialized patient support, or assistance with insurance navigation. By providing comprehensive support, these programs can help patients better manage their condition and adhere to their treatment plans.
It is important to note that the availability and specifics of pharmaceutical company programs can vary. Patients are encouraged to research and contact individual companies to understand the programs they offer and determine their eligibility. Additionally, staying informed about updates and changes in these programs can help patients take advantage of any new opportunities for assistance.
Medical Insurance Gaps: How Long is Too Long?
You may want to see also
Explore related products
The cost of living with MS
The cost of living with multiple sclerosis (MS) can be a heavy financial burden. It is a chronic disease that requires lifelong treatment, and the costs of managing the condition can be significant. The average cost of treatment per year is estimated to be around $88,487, including both direct and indirect costs. Direct treatment costs include doctor's appointments and prescription medications to slow the disease's progression, while indirect costs cover everyday living expenses associated with MS, such as early retirement and home modifications for accessibility.
The cost of MS treatment has been increasing over the years, with newer disease-modifying treatments (DMTs) entering the market at higher prices. The Multiple Sclerosis Society reports that some medications have increased by about 1,000% in the last 20 years. This has resulted in out-of-pocket expenses for patients, even with insurance coverage. For those with Medicare, additional costs may arise due to certain treatments or medications not being covered.
To manage the financial burden, patients can explore various options. Firstly, contacting patient assistance programs offered by pharmaceutical companies, such as those listed by the National Multiple Sclerosis Society and the Multiple Sclerosis Association of America, can help identify eligibility for financial support. These organizations also provide resources for insurance copayments and assistive equipment. Additionally, checking websites like NeedyMeds.org can connect patients to diagnosis-based assistance programs.
Another strategy is to consider secondary insurance to supplement Medicare. A Medicare supplement (Medigap) plan can help cover some out-of-pocket costs. Additionally, manufacturer and pharmacy coupons may be available to offset the cost of certain medications. It is also beneficial to discuss concerns about treatment costs with healthcare providers and insurance companies, as they may provide guidance on cost management or alternative treatment options.
While the financial aspect of living with MS can be challenging, there are resources available to help patients navigate these costs. By being proactive and seeking out assistance, individuals can focus on their well-being and effectively manage their condition.
Midyear Medical Insurance: Adding Employees to Your Plan
You may want to see also
Frequently asked questions
The cost of MS medication with insurance varies depending on the type of insurance and the medication. For example, OCREVUS (ocrelizumab) currently costs $78,858 annually, but most people will not pay the full amount and will instead pay an out-of-pocket cost determined by their insurance provider.
The cost of MS medication without insurance can be high. The average yearly cost of MS treatment is estimated to be around $88,487, including direct treatment costs like medication and doctor's appointments, as well as non-medical costs associated with everyday living with MS.
There are several ways to reduce the cost of MS medication. Firstly, consider contacting patient assistance programs offered by pharmaceutical companies, non-profit assistance foundations, or diagnosis-based assistance programs to see if you are eligible for financial help. Additionally, look into Medicare supplement (Medigap) plans or insurance plans that cover MS medications, such as Kesimpta (ofatumumab) and Betaseron (interferon beta-1b).
While MS medications can be expensive, there are some options that may be more affordable. For example, Acthar gel, a medication used to treat MS, currently has no generic alternatives and may be covered by Medicare or insurance plans. Additionally, some medications like Avonex (interferon beta-1a) have partnered with programs like GoodRx to reduce the price for prescriptions through co-pay cards and assistance programs.
